Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab combined with guadecitabine and mocetinostat is displayed, with details on its design, eligibility, participating locations, and measured outcomes. The record indicates that the study is active but no longer recruiting.
    Difference
    49%
    Check dated 2026-11-08T13:00:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T13:29:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:20:32.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:35:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The error page’s footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the full study details with a minimal error screen. This indicates the ClinicalTrials.gov record for NCT03220477 is not accessible at this time.
    Difference
    19%
    Check dated 2026-09-20T20:08:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.